Development of a High-Throughput Screening Assay for Inhibitors of Aggrecan Cleavage Using Luminescent Oxygen Channeling (AlphaScreenTM) (original) (raw)

Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro

Peter Roughley

Biochemical Journal, 1999

View PDFchevron_right

Aggrecanase: A Target for the Design of Inhibitors of Cartilage Degradation

Robert Newton

Annals of the New York Academy of Sciences, 1999

View PDFchevron_right

Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments1

André Struglics

Osteoarthritis and Cartilage, 2006

View PDFchevron_right

Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage

Peter Roughley

Osteoarthritis and Cartilage, 2008

View PDFchevron_right

The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism

John Mort

Biochemical Journal, 2002

View PDFchevron_right

Recombinant Human Aggrecan G1-G2 Exhibits Native Binding Properties and Substrate Specificity for Matrix Metalloproteinases and Aggrecanase

Karena Last

Journal of Biological Chemistry, 1999

View PDFchevron_right

A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs

Peter Mitchell

Osteoarthritis and Cartilage, 2010

View PDFchevron_right

The cleavage of biglycan by aggrecanases

Peter Roughley

Osteoarthritis and Cartilage, 2006

View PDFchevron_right

Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants

Karena Last

2000

View PDFchevron_right

The structure of aggrecan fragments in human synovial fluid. evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis

John Sandy

Arthritis & Rheumatism, 1993

View PDFchevron_right

Cleavage of the Carboxyl Tail from the G3 Domain of Aggrecan but Not Versican and Identification of the Amino Acids Involved in the Degradation

Burton Yang

Journal of Biological Chemistry, 2002

View PDFchevron_right

Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay

David Buttle

Molecular Pathology, 1997

View PDFchevron_right

The Interglobular Domain of Cartilage Aggrecan Is Cleaved by Hemorrhagic Metalloproteinase HT-d (Atrolysin C) at the Matrix Metalloproteinase and Aggrecanase Sites

Jay Fox

Journal of Biological Chemistry, 1998

View PDFchevron_right

Aggrecan Turnover in Human Articular Cartilage: Use of Aspartic Acid Racemization as a Marker of Molecular Age

Nathali Kaushansky

View PDFchevron_right

Soluble Recombinant Neprilysin Induces Aggrecanase-Mediated Cleavage of Aggrecan in Cartilage Explant Cultures

Caroline Hoemann

Archives of Biochemistry and Biophysics, 2001

View PDFchevron_right

Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity

André Struglics

Arthritis research & therapy, 2017

View PDFchevron_right

The role of aggrecan in normal and osteoarthritic cartilage

John Mort

Journal of Experimental Orthopaedics, 2014

View PDFchevron_right

Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage

Peter Roughley

European cells & materials

View PDFchevron_right

Coincubation of Bovine Synovial or Capsular Tissue with Cartilage Generates a Soluble “Aggrecanase” Activity

David Buttle

Biochemical and Biophysical Research Communications, 1999

View PDFchevron_right

Degradation of cartilage aggrecan by collagenase-3 (MMP-13)

Karena Last

FEBS Letters, 1996

View PDFchevron_right

Variations in aggrecan structure modulate its susceptibility to aggrecanases

John Mort, Peter Roughley

Biochemical Journal, 2003

View PDFchevron_right

Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage

Demitrios Vynios

The Biochemical journal, 1996

View PDFchevron_right

A comparison of different purification methods of aggrecan fragments from human articular cartilage and synovial fluid

André Struglics

Matrix Biology, 2010

View PDFchevron_right

TIMP-3 Inhibition of ADAMTS-4 (Aggrecanase-1) Is Modulated by Interactions between Aggrecan and the C-terminal Domain of ADAMTS-4

Augustin Amour

Journal of Biological Chemistry, 2007

View PDFchevron_right

Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy

Laurel Ng, John Sandy

Journal of Structural Biology, 2003

View PDFchevron_right

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown

Corinne Gendron

Arthritis Research Therapy, 2005

View PDFchevron_right

Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage

Karena Last

Nature Protocols, 2011

View PDFchevron_right

Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study

André Struglics

Arthritis Research & Therapy, 2009

View PDFchevron_right

MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein

Peter Roughley

Matrix Biology, 2011

View PDFchevron_right

Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases

André Struglics

Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society, 2009

View PDFchevron_right

The Folded Modules of Aggrecan G3 Domain Exert Two Separable Functions in Glycosaminoglycan Modification and Product Secretion

Burton Yang

Journal of Biological Chemistry, 2001

View PDFchevron_right

ELISA for the core protein of the cartilage large aggregating proteoglycan, aggrecan: Comparison with the concentrations of immunogenic keratan sulphate in synovial fluid, serum and urine

Jens-christian Poulsen

Clinica Chimica Acta, 1994

View PDFchevron_right

Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site

Peter Roughley

Arthritis research & therapy, 2006

View PDFchevron_right

Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase

Tim Hardingham

1991

View PDFchevron_right